Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 812-839
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets
F. Javier Luque, Diego Muñoz‐Torrero
Accounts of Chemical Research (2024)
Open Access | Times Cited: 14
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease
Michele Rossi, Michela Freschi, Luciana de Camargo Nascente, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4972-4990
Open Access | Times Cited: 87
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 37
Tacrine-Based Hybrids: Past, Present, and Future
Anna Bubley, Alexander S. Erofeev, Peter Gorelkin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1717-1717
Open Access | Times Cited: 22
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32
Capsaicin: A Potential Treatment to Improve Cerebrovascular Function and Cognition in Obesity and Ageing
Tammy Thornton, Dean E. Mills, Edward Bliss
Nutrients (2023) Vol. 15, Iss. 6, pp. 1537-1537
Open Access | Times Cited: 15
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 6
Essential oils of Plumeria alba L. and Plumeria rubra L. growing in Egypt: GC/MS analysis, molecular dynamics and in-vitro anti-cholinesterase activity
Riham A. El‐Shiekh, Dalia E. Ali, Asmaa A. Mandour, et al.
Industrial Crops and Products (2024) Vol. 221, pp. 119316-119316
Closed Access | Times Cited: 5
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Causal Impacts of Psychiatric Disorders on Cognition and the Mediating Effect of Oxidative Stress: A Mendelian Randomization Study
Yan Gao, Dan-dan Wang, Qian Wang, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 162-162
Open Access
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
Philipp Spatz, Sophie A. M. Steinmüller, Anna Tutov, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6414-6435
Open Access | Times Cited: 14
Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease
Juan‐yue Long, Fengxue Qin, Jinchong Luo, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107026-107026
Closed Access | Times Cited: 14
Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
Ashraf K. El‐Damasy, Jong‐Eun Park, Hyun Ji Kim, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 83-83
Open Access | Times Cited: 11
Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities
Ling Lv, Mireguli Maimaitiming, Yan Huang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115346-115346
Closed Access | Times Cited: 11
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Rui Zhao, Junlong Zhu, Xiaoying Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116037-116037
Closed Access | Times Cited: 11
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Natural products as a source of cholinesterase inhibitors
Pamella Christina Ortega de Oliveira, Gabriel Matias da Silva, Quézia B. Cass, et al.
Pharmacological Research - Natural Products (2024) Vol. 5, pp. 100099-100099
Closed Access | Times Cited: 3
Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
Chandran Remya, K.V. Dileep, Eeda Koti Reddy, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4517-4537
Open Access | Times Cited: 24
Exploration of Neuroprotective Properties of a Naturally Inspired Multifunctional Molecule (F24) against Oxidative Stress and Amyloid β Induced Neurotoxicity in Alzheimer’s Disease Models
Yash Pal Singh, Navneet Kumar, Khushbu Priya, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 27-42
Closed Access | Times Cited: 21
HDAC1/MAO-B dual inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids
Chuansheng Yao, Xiaoying Jiang, Rui Zhao, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105724-105724
Closed Access | Times Cited: 14
A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning
Ophélie da Silva, Nicolas Probst, Christophe Landry, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4649-4666
Open Access | Times Cited: 14
Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
Marwa El‐Hussieny, Mansoura A. Abd‐El‐Maksoud, Fouad M. Soliman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top